Latest Breaking News On - Enrico bastianelli - Page 1 : vimarsana.com

TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024

TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleUnited statesFrance generalWaals gewestCzech republicJohan dreesenEnrico bastianelliMeeting of the companyCompany onCompany board of directorsRegulatory newsOrdinary general meetingGeneral meetingChief executive officerBrakke consultingYear report

TheraVet Reports an 99% Increase in BIOCERA-VET Units Sold in Q4 2023

TheraVet Reports an 99% Increase in BIOCERA-VET Units Sold in Q4 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Waals gewestBruxelles capitaleFrance generalStefan klotterArthur rouillNewcap belgiqueMartin nicolas fossiezEnrico bastianelliFinancial communicationsNorth americaUnited statesChief executive officerLinkedin facebookOperating officerEve monfortDie performance strategie

TheraVet Reports Further Achievements on Its Osteosarcoma Program

GOSSELIES, Belgium, December 06, 2023 Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, updates on the Osteosarcoma Program achievements in 2023.

United kingdomWaals gewestBruxelles capitaleFrance generalUnited statesMartin nicolas fossiezOsteosarcoma cementoplastyNewcap belgiqueEnrico bastianelliArthur rouillUniversity of floridaOsteosarcoma reference centersFinancial communicationsOsteosarcoma programRegulatory newsChief executive officer

TheraVet: Significant Sales Progression for BIOCERA-VET® in Q3 2023

GOSSELIES, Belgium, November 08, 2023 Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces significant progression for BIOCERA-VET® line in the third quarter of 2023.

France generalWaals gewestUnited kingdomBruxelles capitaleNew zealandCzech republicArthur rouillMartin nicolas fossiezNewcap belgiqueEnrico bastianelliFinancial communicationsFrance association franRegulatory newsNorth americaUnited statesLassociation fran

TheraVet: Significant Sales Progression for BIOCERA-VET in Q3 2023

TheraVet: Significant Sales Progression for BIOCERA-VET in Q3 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalBruxelles capitaleWaals gewestCzech republicUnited kingdomNew zealandMartin nicolas fossiezEnrico bastianelliArthur rouillNewcap belgiqueFrance association franFinancial communicationsNorth americaUnited statesLassociation franAnimaux de compagnie